Summary for ARTG Entry:
Smith & Nephew Pty Ltd - ANTHOLOGY Porous Plus HA Femoral Component - Coated femoral stem
ARTG entry for
Medical Device Included Class III
Smith & Nephew Pty Ltd
PO Box 393, North Ryde, NSW, 1670
ARTG Start Date
Medical Device Class III
- The inclusion of the kind of device in the ARTG is subject to compliance with all conditions placed or imposed on the ARTG entry. Refer Part 4-5,
Division 2 (Conditions) of the Therapeutic Goods Act 1989 and Part 5, Division 5.2 (Conditions) of the Therapeutic Goods (Medical Devices) Regulations
2002 for relevant information.
- Breaching conditions of the inclusion related to the device of the kind may lead to suspension or cancellation of the ARTG entry; may be a criminal
offence; and civil penalties may apply.
Smith & Nephew Inc Orthopaedic Division
1450 E Brooks Road
Memphis, TN, 38116
United States Of America
1. ANTHOLOGY Porous Plus HA Femoral Component - Coated femoral stem prosthesis, modular
Single Device Product
34191 Coated femoral stem prosthesis, modular
A porous, hydroxyapatite-coated one-piece titanium alloy femoral component is inserted into a prepared
femoral canal following femoral head osteotomy. The femoral canal is rasped with sequential broaches
until it reaches the templated stem size. Following trial reduction with a broach/trial, standard or high offset
neck trial, and femoral head trial, a stem inserter is used to rotate and place the stem. It is seated into the
femur with a mallet and a femoral head is impacted on the neck taper.
A sterile femoral component of a total hip system. It is designed to mate with either a femoral head or a
femoral sleeve and modular head. It is intended to be used in primary total hip replacement and without
Hip components are indicated for individuals undergoing primary and revision surgery where other
treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory
degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis,
traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant.
Hip components are also indicated for inflammatory degenerative joint disease including rheumatoid
arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; treatments of
nonunion, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement
that are unmanageable using other techniques; endoprosthesis, femoral osteotomy, or Girdlestone
resection; fracture-dislocation of the hip; and correction of deformity.
Offset Standard or High
Size 1 to 12
No Specific Conditions included on Record
© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.
Page 1 of
Produced at 10.11.2017 at 11:41:03 AEDT
This is not an ARTG Certificate document.
The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.
Visit www.tga.gov.au for contact information